395C012E-524D-4DD2-A8CD-4C2D39FFE848.png
Leading TechBio Investment Firm ARTIS Ventures Announces 2023 Class of Healthcare and Life Sciences Fellows
January 12, 2024 12:00 ET | ARTIS Ventures
San Francisco, CA, Jan. 12, 2024 (GLOBE NEWSWIRE) -- ARTIS Ventures, a leading venture firm pioneering investments in the TechBio space, today announced its newest class of AV Fellows. Selected from...
Delivering Next Generation Addiction Recovery, Affect Therapeutics Raises $16 Million in Series A Funding Led by ARTIS Ventures
July 12, 2023 07:00 ET | ARTIS Ventures
McLean, VA, July 12, 2023 (GLOBE NEWSWIRE) -- Affect Therapeutics (“Affect”), a company reimagining addiction treatment for the digital age, today announces a $16 million Series A led by...
With the Potential to Revolutionize Personalized Health, Range Biotechnologies Receives $5.2 Million in Seed Funding Led by TechBio-Focused ARTIS Ventures
June 12, 2023 11:00 ET | ARTIS Ventures
San Francisco, CA, June 12, 2023 (GLOBE NEWSWIRE) -- Range Biotechnologies (“Range Bio”), a proteomics-focused biotech company that has developed an innovative translational platform to enable...
395C012E-524D-4DD2-A8CD-4C2D39FFE848.png
Leading TechBio Investment Firm ARTIS Ventures Announces 2022 Class of Healthcare and Life Sciences Fellows
December 14, 2022 11:00 ET | ARTIS Ventures
San Francisco , Dec. 14, 2022 (GLOBE NEWSWIRE) -- ARTIS Ventures, a leading venture firm pioneering investments in the TechBio space, today announced its newest class of AV Fellows. The 2022 fellows...
395C012E-524D-4DD2-A8CD-4C2D39FFE848.png
ARTIS Ventures Welcomes Henry Klingenstein to Its Investment Team
October 10, 2022 11:00 ET | ARTIS Ventures
San Francisco, Oct. 10, 2022 (GLOBE NEWSWIRE) -- ARTIS Ventures, a leading venture firm pioneering investments in the TechBio space, today announced Henry Klingenstein has joined the investment...
395C012E-524D-4DD2-A8CD-4C2D39FFE848.png
ARTIS Ventures Promotes Ameena El-Bibany to Partner
December 15, 2021 10:40 ET | ARTIS Ventures
San Francisco, CA, Dec. 15, 2021 (GLOBE NEWSWIRE) -- ARTIS Ventures, a San Francisco-based venture firm focused on pioneering investments at the intersection of life sciences and computer sciences,...
395C012E-524D-4DD2-A8CD-4C2D39FFE848.png
ARTIS Ventures Announces 2021 Class of Healthcare and Life Sciences Fellows
August 03, 2021 13:13 ET | ARTIS Ventures
San Francisco, CA, Aug. 03, 2021 (GLOBE NEWSWIRE) -- ARTIS Ventures (“AV”), a venture firm focused on pioneering investments in biotech, health, and life sciences, today announced the candidates...
Creating Next Generation Smart Cell Therapies: Outpace Bio Receives $30 Million in Series A Funding Led by ARTIS Ventures and Lyell Immunopharma Inc.
March 31, 2021 09:00 ET | ARTIS Ventures
Seattle, WA, March 31, 2021 (GLOBE NEWSWIRE) -- Outpace Bio, a biotechnology company building a platform to create next-generation smart cell therapies, today announced the closing of a $30 million...
Second Front Systems Raises $6 Million to Provide Immediate Impact to National Security, led by ARTIS Ventures
July 07, 2020 11:00 ET | ARTIS Ventures
San Francisco, CA, July 07, 2020 (GLOBE NEWSWIRE) -- Second Front Systems, a software company working to disrupt the traditional aerospace and defense industry by acting as a beachhead for...
ARTIS Ventures Welcomes Jeff Kindler as Operating Partner
April 20, 2020 12:00 ET | ARTIS Ventures
SAN FRANCISCO, April 20, 2020 (GLOBE NEWSWIRE) -- ARTIS Ventures, a venture firm focused on pioneering investments at the intersection of life sciences and computer sciences, today announced that...